Confluent DuraSeal 8.1% Infection Rate Places Focus On Risk/Benefit Ratio
This article was originally published in The Gray Sheet
Executive Summary
Confluent Surgical's DuraSeal sealant should be approved for adjunctive dural closure, contingent on an infection risk warning in the label and a postmarket study, according to FDA's Neurological Devices Panel